2024-05-09 04:43:12, GGRNA : RefSeq release 60 (20130726)
LOCUS NM_020530 1869 bp mRNA linear PRI 15-JUN-2013 DEFINITION Homo sapiens oncostatin M (OSM), mRNA. ACCESSION NM_020530 VERSION NM_020530.4 GI:317008625 KEYWORDS RefSeq. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 1869) AUTHORS Jostins,L., Ripke,S., Weersma,R.K., Duerr,R.H., McGovern,D.P., Hui,K.Y., Lee,J.C., Schumm,L.P., Sharma,Y., Anderson,C.A., Essers,J., Mitrovic,M., Ning,K., Cleynen,I., Theatre,E., Spain,S.L., Raychaudhuri,S., Goyette,P., Wei,Z., Abraham,C., Achkar,J.P., Ahmad,T., Amininejad,L., Ananthakrishnan,A.N., Andersen,V., Andrews,J.M., Baidoo,L., Balschun,T., Bampton,P.A., Bitton,A., Boucher,G., Brand,S., Buning,C., Cohain,A., Cichon,S., D'Amato,M., De Jong,D., Devaney,K.L., Dubinsky,M., Edwards,C., Ellinghaus,D., Ferguson,L.R., Franchimont,D., Fransen,K., Gearry,R., Georges,M., Gieger,C., Glas,J., Haritunians,T., Hart,A., Hawkey,C., Hedl,M., Hu,X., Karlsen,T.H., Kupcinskas,L., Kugathasan,S., Latiano,A., Laukens,D., Lawrance,I.C., Lees,C.W., Louis,E., Mahy,G., Mansfield,J., Morgan,A.R., Mowat,C., Newman,W., Palmieri,O., Ponsioen,C.Y., Potocnik,U., Prescott,N.J., Regueiro,M., Rotter,J.I., Russell,R.K., Sanderson,J.D., Sans,M., Satsangi,J., Schreiber,S., Simms,L.A., Sventoraityte,J., Targan,S.R., Taylor,K.D., Tremelling,M., Verspaget,H.W., De Vos,M., Wijmenga,C., Wilson,D.C., Winkelmann,J., Xavier,R.J., Zeissig,S., Zhang,B., Zhang,C.K., Zhao,H., Silverberg,M.S., Annese,V., Hakonarson,H., Brant,S.R., Radford-Smith,G., Mathew,C.G., Rioux,J.D., Schadt,E.E., Daly,M.J., Franke,A., Parkes,M., Vermeire,S., Barrett,J.C. and Cho,J.H. CONSRTM International IBD Genetics Consortium (IIBDGC) TITLE Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease JOURNAL Nature 491 (7422), 119-124 (2012) PUBMED 23128233 REFERENCE 2 (bases 1 to 1869) AUTHORS David,E., Tirode,F., Baud'huin,M., Guihard,P., Laud,K., Delattre,O., Heymann,M.F., Heymann,D., Redini,F. and Blanchard,F. TITLE Oncostatin M is a growth factor for Ewing sarcoma JOURNAL Am. J. Pathol. 181 (5), 1782-1795 (2012) PUBMED 22982441 REMARK GeneRIF: OSM induced proliferation of Ewing sarcoma cell lines. REFERENCE 3 (bases 1 to 1869) AUTHORS Ko,H.S., Kang,H.K., Kim,H.S., Choi,S.K., Park,I.Y. and Shin,J.C. TITLE The effects of oncostatin M on trophoblast cells: influence on matrix metalloproteinases-2 and -9, and invasion activity JOURNAL Placenta 33 (11), 908-913 (2012) PUBMED 22931588 REMARK GeneRIF: Data suggest that OSM enhances invasion activities of extravillous trophoblasts during placentation through increased enzyme activity of MMP-2 (primarily) and MMP-9 (to some extent). REFERENCE 4 (bases 1 to 1869) AUTHORS Chollangi,S., Mather,T., Rodgers,K.K. and Ash,J.D. TITLE A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor JOURNAL J. Biol. Chem. 287 (39), 32848-32859 (2012) PUBMED 22829597 REMARK GeneRIF: A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor. REFERENCE 5 (bases 1 to 1869) AUTHORS West,N.R., Murphy,L.C. and Watson,P.H. TITLE Oncostatin M suppresses oestrogen receptor-alpha expression and is associated with poor outcome in human breast cancer JOURNAL Endocr. Relat. Cancer 19 (2), 181-195 (2012) PUBMED 22267707 REMARK GeneRIF: Oncostatin M signaling may cause suppression of estrogen receptor-alpha and disease progression i breast cancer. Publication Status: Online-Only REFERENCE 6 (bases 1 to 1869) AUTHORS Gearing,D.P., Comeau,M.R., Friend,D.J., Gimpel,S.D., Thut,C.J., McGourty,J., Brasher,K.K., King,J.A., Gillis,S., Mosley,B. et al. TITLE The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor JOURNAL Science 255 (5050), 1434-1437 (1992) PUBMED 1542794 REFERENCE 7 (bases 1 to 1869) AUTHORS Miles,S.A., Martinez-Maza,O., Rezai,A., Magpantay,L., Kishimoto,T., Nakamura,S., Radka,S.F. and Linsley,P.S. TITLE Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells JOURNAL Science 255 (5050), 1432-1434 (1992) PUBMED 1542793 REFERENCE 8 (bases 1 to 1869) AUTHORS Gearing,D.P. and Bruce,A.G. TITLE Oncostatin M binds the high-affinity leukemia inhibitory factor receptor JOURNAL New Biol. 4 (1), 61-65 (1992) PUBMED 1536831 REFERENCE 9 (bases 1 to 1869) AUTHORS Rose,T.M. and Bruce,A.G. TITLE Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6 JOURNAL Proc. Natl. Acad. Sci. U.S.A. 88 (19), 8641-8645 (1991) PUBMED 1717982 REFERENCE 10 (bases 1 to 1869) AUTHORS Kallestad,J.C., Shoyab,M. and Linsley,P.S. TITLE Disulfide bond assignment and identification of regions required for functional activity of oncostatin M JOURNAL J. Biol. Chem. 266 (14), 8940-8945 (1991) PUBMED 2026606 COMMENT REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from BC011589.1. On Jan 6, 2011 this sequence version replaced gi:28178862. Summary: Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. This gene encodes a growth regulator which inhibits the proliferation of a number of tumor cell lines. It regulates cytokine production, including IL-6, G-CSF and GM-CSF from endothelial cells. [provided by RefSeq, Jul 2008]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: BC011589.1, BM544068.1 [ECO:0000332] RNAseq introns :: mixed/partial sample support ERS025086, ERS025087 [ECO:0000350] ##Evidence-Data-END## COMPLETENESS: full length. FEATURES Location/Qualifiers source 1..1869 /organism="Homo sapiens" /mol_type="mRNA" /db_xref="taxon:9606" /chromosome="22" /map="22q12.2" gene 1..1869 /gene="OSM" /note="oncostatin M" /db_xref="GeneID:5008" /db_xref="HGNC:8506" /db_xref="HPRD:01300" /db_xref="MIM:165095" exon 1..75 /gene="OSM" /inference="alignment:Splign:1.39.8" CDS 42..800 /gene="OSM" /note="oncostatin-M" /codon_start=1 /product="oncostatin-M preproprotein" /protein_id="NP_065391.1" /db_xref="GI:10092621" /db_xref="CCDS:CCDS13873.1" /db_xref="GeneID:5008" /db_xref="HGNC:8506" /db_xref="HPRD:01300" /db_xref="MIM:165095" /translation="
MGVLLTQRTLLSLVLALLFPSMASMAAIGSCSKEYRVLLGQLQKQTDLMQDTSRLLDPYIRIQGLDVPKLREHCRERPGAFPSEETLRGLGRRGFLQTLNATLGCVLHRLADLEQRLPKAQDLERSGLNIEDLEKLQMARPNILGLRNNIYCMAQLLDNSDTAEPTKAGRGASQPPTPTPASDAFQRKLEGCRFLHGYHRFMHSVGRVFSKWGESPNRSRRHSPHQALRKGVRRTRPSRKGKRLMTRGQLPR
" sig_peptide 42..116 /gene="OSM" proprotein 117..797 /gene="OSM" /product="oncostatin-M proprotein" mat_peptide 117..704 /gene="OSM" /product="oncostatin-M" misc_feature order(132..134,495..497) /gene="OSM" /experiment="experimental evidence, no additional details recorded" /note="disulfide bridge bond" /citation=[10] misc_feature 150..668 /gene="OSM" /note="LIF / OSM family; Region: LIF_OSM; pfam01291" /db_xref="CDD:201714" misc_feature order(261..263,615..617) /gene="OSM" /experiment="experimental evidence, no additional details recorded" /note="disulfide bridge bond" /citation=[10] exon 76..218 /gene="OSM" /inference="alignment:Splign:1.39.8" exon 219..1854 /gene="OSM" /inference="alignment:Splign:1.39.8" STS 365..818 /gene="OSM" /standard_name="GDB:194718" /db_xref="UniSTS:155797" STS 837..1018 /gene="OSM" /standard_name="STS-M27288" /db_xref="UniSTS:55412" variation 1106 /gene="OSM" /replace="c" /replace="t" /db_xref="dbSNP:2070889" variation 1136 /gene="OSM" /replace="c" /replace="t" /db_xref="dbSNP:2070890" STS 1253..1460 /gene="OSM" /standard_name="GDB:452636" /db_xref="UniSTS:157402" polyA_site 1854 /gene="OSM" ORIGIN
gtcacccccagcgggcgcgggccggagcacgggcacccagcatgggggtactgctcacacagaggacgctgctcagtctggtccttgcactcctgtttccaagcatggcgagcatggcggctataggcagctgctcgaaagagtaccgcgtgctccttggccagctccagaagcagacagatctcatgcaggacaccagcagactcctggacccctatatacgtatccaaggcctggatgttcctaaactgagagagcactgcagggagcgccccggggccttccccagtgaggagaccctgagggggctgggcaggcggggcttcctgcagaccctcaatgccacactgggctgcgtcctgcacagactggccgacttagagcagcgcctccccaaggcccaggatttggagaggtctgggctgaacatcgaggacttggagaagctgcagatggcgaggccgaacatcctcgggctcaggaacaacatctactgcatggcccagctgctggacaactcagacacggctgagcccacgaaggctggccggggggcctctcagccgcccacccccacccctgcctcggatgcttttcagcgcaagctggagggctgcaggttcctgcatggctaccatcgcttcatgcactcagtggggcgggtcttcagcaagtggggggagagcccgaaccggagccggagacacagcccccaccaggccctgaggaagggggtgcgcaggaccagaccctccaggaaaggcaagagactcatgaccaggggacagctgccccggtagcctcgagagcaccccttgccggtgaaggatgcggcaggtgctctgtggatgagaggaaccatcgcaggatgacagctcccgggtccccaaacctgttcccctctgctactagccactgagaagtgcactttaagaggtgggagctgggcagacccctctacctcctccaggctgggagacagagtcaggctgttgcgctcccacctcagccccaagttccccaggcccagtggggtggccgggcgggccacgcgggaccgactttccattgattcaggggtctgatgacacaggctgactcatggccgggctgactgcccccctgccttgctccccgaggcctgccggtccttccctctcatgacttgcagggccgttgcccccagacttcctcctttccgtgtttctgaaggggaggtcacagcctgagctggcctcctatgcctcatcatgtcccaaaccagacacctggatgtctgggtgacctcactttaggcagctgtaacagcggcagggtgtcccaggagccctgatccgggggtccagggaatggagctcaggtcccaggccagccccgaagtcgccacgtggcctggggcaggtcactttacctctgtggacctgttttctctttgtgaagctagggagttagaggctgtacaaggcccccactgcctgtcggttgcttggattccctgacgtaaggtggatattaaaaatctgtaaatcaggacaggtggtgcaaatggcgctgggaggtgtacacggaggtctctgtaaaagcagacccacctcccagcgccgggaagcccgtcttgggtcctcgctgctggctgctccccctggtggtggatcctggaattttctcacgcaggagccattgctctcctagagggggtctcagaaactgcgaggccagttccttggagggacatgactaatttatcgatttttatcaatttttatcagttttatatttataagccttatttatgatgtatatttaatgttaatattgtgcaaacttatatttaaaacttgcctggtttctaaaaaaaaaaaaaaaaaa
//
ANNOTATIONS from NCBI Entrez Gene (20130726): GeneID:5008 -> Molecular function: GO:0005125 [cytokine activity] evidence: IDA GeneID:5008 -> Molecular function: GO:0005147 [oncostatin-M receptor binding] evidence: IPI GeneID:5008 -> Molecular function: GO:0008083 [growth factor activity] evidence: IDA GeneID:5008 -> Biological process: GO:0002675 [positive regulation of acute inflammatory response] evidence: IC GeneID:5008 -> Biological process: GO:0006915 [apoptotic process] evidence: IEA GeneID:5008 -> Biological process: GO:0006955 [immune response] evidence: IEA GeneID:5008 -> Biological process: GO:0007275 [multicellular organismal development] evidence: TAS GeneID:5008 -> Biological process: GO:0007422 [peripheral nervous system development] evidence: IEA GeneID:5008 -> Biological process: GO:0008283 [cell proliferation] evidence: TAS GeneID:5008 -> Biological process: GO:0008284 [positive regulation of cell proliferation] evidence: IDA GeneID:5008 -> Biological process: GO:0008285 [negative regulation of cell proliferation] evidence: TAS GeneID:5008 -> Biological process: GO:0009408 [response to heat] evidence: IEA GeneID:5008 -> Biological process: GO:0033138 [positive regulation of peptidyl-serine phosphorylation] evidence: IDA GeneID:5008 -> Biological process: GO:0040008 [regulation of growth] evidence: IEA GeneID:5008 -> Biological process: GO:0042503 [tyrosine phosphorylation of Stat3 protein] evidence: IEA GeneID:5008 -> Biological process: GO:0042506 [tyrosine phosphorylation of Stat5 protein] evidence: IEA GeneID:5008 -> Biological process: GO:0042508 [tyrosine phosphorylation of Stat1 protein] evidence: IEA GeneID:5008 -> Biological process: GO:0043410 [positive regulation of MAPK cascade] evidence: IDA GeneID:5008 -> Biological process: GO:0045835 [negative regulation of meiosis] evidence: IEA GeneID:5008 -> Biological process: GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] evidence: IDA GeneID:5008 -> Biological process: GO:0046888 [negative regulation of hormone secretion] evidence: IDA GeneID:5008 -> Biological process: GO:0048266 [behavioral response to pain] evidence: IEA GeneID:5008 -> Biological process: GO:0050731 [positive regulation of peptidyl-tyrosine phosphorylation] evidence: IDA GeneID:5008 -> Biological process: GO:0051781 [positive regulation of cell division] evidence: IEA GeneID:5008 -> Cellular component: GO:0005615 [extracellular space] evidence: IEA GeneID:5008 -> Cellular component: GO:0005900 [oncostatin-M receptor complex] evidence: IDA
by
@meso_cacase at
DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.